NEOGENOMICS INC cotiza a 16.66 USD y tiene una capitalización bursátil de $2.2B. En los últimos 12 meses ha facturado $766M con un margen de flujo de caja libre del -3.0%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing s…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.05 | $0.01 | $0.06 |
| Estimado | $0.06 | $0.03 | — | $0.04 |
| Sorpresa | — | +66.7% | — | +50.0% |
| Métrica | NEO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 43.2% | 57.0% | -13.8% |
| Operating Margin | -15.9% | -38.6% | +22.7% |
| Net Margin | -14.8% | -33.6% | +18.7% |
| FCF Margin | -3.0% | -13.9% | +10.9% |
| ROE | -12.9% | -40.4% | +27.5% |
| ROA | -7.9% | -32.0% | +24.1% |
| Current Ratio | 4.26 | 2.84 | +1.42 |
| Debt / Equity | 0.41 | 0.28 | +0.13 |